Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Primary Myelofibrosis 41Myeloproliferative Disorders 30Polycythemia Vera 28Leukemia, Myeloid, Acute 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Leukemia 17Myelodysplastic Syndromes 15Thrombocythemia, Essential 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Neoplasms 9Multiple Myeloma 9Graft vs Host Disease 9Breast Neoplasms 9Pancreatic Neoplasms 8Leukemia, Myelomonocytic, Chronic 8Recurrence 7Myelodysplastic-Myeloproliferative Diseases 7Lymphoma, Non-Hodgkin 6Leukemia, Lymphocytic, Chronic, B-Cell 6Hematologic Neoplasms 6Prostatic Neoplasms 5Lymphoma, T-Cell 5Lymphoma 5Leukemia, Myeloid, Chronic-Phase 5Hodgkin Disease 5Hematologic Diseases 5Colorectal Neoplasms 5Thrombocytosis 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Carcinoma, Non-Small-Cell Lung 4

Interventions

Blood Specimen Collection 8Magnetic Resonance Spectroscopy 5Pentoxifylline 4Liver Transplantation 4Tenofovir 3Specimen Handling 3High-Energy Shock Waves 3Tocopherols 2Sorafenib 2Simvastatin 2Low-Level Light Therapy 2Gemcitabine 2tremelimumab 1sonidegib 1sofosbuvir-velpatasvir drug combination 1ruxolitinib 1peginterferon alfa-2a 1navitoclax 1maltodextrin 1hepatitis B hyperimmune globulin 1esmolol 1epigallocatechin gallate 1durvalumab 1contrast agent BR1 1bavituximab 1atezolizumab 1apixaban 1alpha-Tocopherol 1adefovir dipivoxil 1Viusid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrosis × ruxolitinib × Clear all
NCT01981850 2022-01-05

A Phase 2 Study of RO7490677 In Participants With Myelofibrosis

Hoffmann-La Roche

Phase 2 Completed
125 enrolled 38 charts
Myeloid

Fibrosis, Polycythemia Vera, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡